Kura Oncology Inc. (NASDAQ:KURA) saw unusually-high trading volume on Thursday . Approximately 4,560,252 shares traded hands during trading, an increase of 724% from the previous session’s volume of 553,119 shares.The stock last traded at $5.71 and had previously closed at $4.36.

KURA has been the topic of a number of research analyst reports. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $16.00 price objective on shares of Kura Oncology in a report on Tuesday, June 21st. Zacks Investment Research lowered shares of Kura Oncology from a “buy” rating to a “hold” rating in a report on Tuesday, May 17th.

The stock’s 50-day moving average price is $3.74 and its 200-day moving average price is $3.65. The firm’s market capitalization is $96.63 million.

Kura Oncology (NASDAQ:KURA) last released its earnings results on Wednesday, August 10th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.34) by $0.02. Analysts anticipate that Kura Oncology Inc. will post ($1.70) EPS for the current fiscal year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.